drugset / Trial / NCT07403097
Study of CD19 CAR-T Therapy for Refractory SLE
NaSingle-groupOpen-labelTreatment
Summary
This is an investigator-initiated trial aimed at assessing the safety and efficacy of PTOC1 cells Injection in the treatment of refractory systemic lupus erythematosus.
Timeline
- Start
- 2026-02
- Primary completion
- 2028-04
- Completion
- 2028-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | PTOC1 | Unknown | 150000 cells/kg | — |
| Subject | PTOC1 | Unknown | 500000 cells/kg | — |
| Subject | PTOC1 | Unknown | 1e+06 cells/kg | — |